<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1986-07-21" modified="2020-10-07" version="257">
<accession>P02730</accession>
<accession>G4V2I6</accession>
<accession>P78487</accession>
<accession>Q1ZZ45</accession>
<accession>Q4KKW9</accession>
<accession>Q4VB84</accession>
<accession>Q9UCY7</accession>
<accession>Q9UDJ1</accession>
<name>B3AT_HUMAN</name>
<protein>
<recommendedName>
<fullName>Band 3 anion transport protein</fullName>
</recommendedName>
<alternativeName>
<fullName>Anion exchange protein 1</fullName>
<shortName>AE 1</shortName>
<shortName>Anion exchanger 1</shortName>
</alternativeName>
<alternativeName>
<fullName>Solute carrier family 4 member 1</fullName>
</alternativeName>
<cdAntigenName>CD233</cdAntigenName>
</protein>
<gene>
<name type="primary">SLC4A1</name>
<name type="synonym">AE1</name>
<name type="synonym">DI</name>
<name type="synonym">EPB3</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1988" name="Biochem. J." volume="256" first="703" last="712">
<title>The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA sequence.</title>
<authorList>
<person name="Tanner M.J.A."/>
<person name="Martin P.G."/>
<person name="High S."/>
</authorList>
<dbReference type="PubMed" id="3223947"/>
<dbReference type="DOI" id="10.1042/bj2560703"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1989" name="Proc. Natl. Acad. Sci. U.S.A." volume="86" first="9089" last="9093">
<title>Cloning and characterization of band 3, the human erythrocyte anion-exchange protein (AE1).</title>
<authorList>
<person name="Lux S.E."/>
<person name="John K.M."/>
<person name="Kopito R.R."/>
<person name="Lodish H.F."/>
</authorList>
<dbReference type="PubMed" id="2594752"/>
<dbReference type="DOI" id="10.1073/pnas.86.23.9089"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Pediatr. Nephrol." volume="21" first="212" last="217">
<title>Recessive distal renal tubular acidosis in Sarawak caused by AE1 mutations.</title>
<authorList>
<person name="Choo K.E."/>
<person name="Nicoli T.K."/>
<person name="Bruce L.J."/>
<person name="Tanner M.J."/>
<person name="Ruiz-Linares A."/>
<person name="Wrong O.M."/>
</authorList>
<dbReference type="PubMed" id="16252102"/>
<dbReference type="DOI" id="10.1007/s00467-005-2061-z"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT ALA-38</scope>
</reference>
<reference key="4">
<citation type="submission" date="2009-09" db="EMBL/GenBank/DDBJ databases">
<title>Novel anion exchanger-1 expression in Southeast Asian populations.</title>
<authorList>
<person name="Hsu K."/>
<person name="Huang S.-Y."/>
<person name="Chi N."/>
<person name="Lin M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue>Blood</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="2005-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="SeattleSNPs variation discovery resource"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS ALA-38; GLU-56; LYS-508 AND ILE-862</scope>
</reference>
<reference key="6">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT HIS-27</scope>
<source>
<tissue>Cerebellum</tissue>
</source>
</reference>
<reference key="8">
<citation type="journal article" date="1989" name="Biochim. Biophys. Acta" volume="998" first="43" last="49">
<title>Primary structure of the cytoplasmic domain of human erythrocyte protein band 3. Comparison with its sequence in the mouse.</title>
<authorList>
<person name="Yannoukakos D."/>
<person name="Vasseur C."/>
<person name="Blouquit Y."/>
<person name="Bursaux E."/>
<person name="Wajcman H."/>
</authorList>
<dbReference type="PubMed" id="2790053"/>
<dbReference type="DOI" id="10.1016/0167-4838(89)90116-7"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1-199; 220-292 AND 347-370</scope>
<scope>ACETYLATION AT MET-1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="1983" name="J. Biol. Chem." volume="258" first="7981" last="7990">
<title>Amino acid sequence of the N alpha-terminal 201 residues of human erythrocyte membrane band 3.</title>
<authorList>
<person name="Kaul R.K."/>
<person name="Murthy S.N.P."/>
<person name="Reddy A.G."/>
<person name="Steck T.L."/>
<person name="Kohler H."/>
</authorList>
<dbReference type="PubMed" id="6345535"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1-201</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1978" name="J. Biol. Chem." volume="253" first="7242" last="7248">
<title>Orientation of the band 3 polypeptide from human erythrocyte membranes. Identification of NH2-terminal sequence and site of carbohydrate attachment.</title>
<authorList>
<person name="Drickamer L.K."/>
</authorList>
<dbReference type="PubMed" id="701248"/>
</citation>
<scope>PROTEIN SEQUENCE OF 1-3</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1993" name="Am. J. Physiol." volume="265" first="F813" last="F821">
<title>Anion exchanger 1 in human kidney and oncocytoma differs from erythroid AE1 in its NH2 terminus.</title>
<authorList>
<person name="Kollert-Jons A."/>
<person name="Wagner S."/>
<person name="Hubner S."/>
<person name="Appelhans H."/>
<person name="Drenckhahn D."/>
</authorList>
<dbReference type="PubMed" id="7506871"/>
<dbReference type="DOI" id="10.1152/ajprenal.1993.265.6.f813"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 66-180 (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="19211" last="19217">
<title>A structural study of the membrane domain of band 3 by tryptic digestion. Conformational change of band 3 in situ induced by alkali treatment.</title>
<authorList>
<person name="Kang D."/>
<person name="Okubo K."/>
<person name="Hamasaki N."/>
<person name="Kuroda N."/>
<person name="Shiraki H."/>
</authorList>
<dbReference type="PubMed" id="1527044"/>
</citation>
<scope>PROTEIN SEQUENCE OF 361-372; 390-399; 604-613; 632-639; 647-656; 699-729; 731-743; 761-781 AND 818-826</scope>
<scope>SYNTHESIS OF 646-656 AND 817-827</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1983" name="Biochem. J." volume="213" first="577" last="586">
<title>The human erythrocyte anion-transport protein. Partial amino acid sequence, conformation and a possible molecular mechanism for anion exchange.</title>
<authorList>
<person name="Brock C.J."/>
<person name="Tanner M.J.A."/>
<person name="Kempf C."/>
</authorList>
<dbReference type="PubMed" id="6615451"/>
<dbReference type="DOI" id="10.1042/bj2130577"/>
</citation>
<scope>PROTEIN SEQUENCE OF 559-630</scope>
</reference>
<reference key="14">
<citation type="journal article" date="1992" name="J. Biol. Chem." volume="267" first="13964" last="13971">
<title>Anion-proton cotransport through the human red blood cell band 3 protein. Role of glutamate 681.</title>
<authorList>
<person name="Jennings M.L."/>
<person name="Smith J.S."/>
</authorList>
<dbReference type="PubMed" id="1352774"/>
</citation>
<scope>PROTEIN SEQUENCE OF 665-688</scope>
<scope>ROLE OF GLU-681</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1995" name="Br. J. Haematol." volume="91" first="804" last="810">
<title>Band 3 Chur: a variant associated with band 3-deficient hereditary spherocytosis and substitution in a highly conserved position of transmembrane segment 11.</title>
<authorList>
<person name="Maillet P."/>
<person name="Vallier A."/>
<person name="Reinhart W.H."/>
<person name="Wyss E.J."/>
<person name="Ott P."/>
<person name="Texier P."/>
<person name="Baklouti F."/>
<person name="Tanner M.J.A."/>
<person name="Delaunay J."/>
<person name="Alloisio N."/>
</authorList>
<dbReference type="PubMed" id="8547122"/>
<dbReference type="DOI" id="10.1111/j.1365-2141.1995.tb05393.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 757-778</scope>
<scope>VARIANT SPH4 ASP-771</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1988" name="J. Biol. Chem." volume="263" first="8232" last="8238">
<title>Localization of the pyridoxal phosphate binding site at the COOH-terminal region of erythrocyte band 3 protein.</title>
<authorList>
<person name="Kawano Y."/>
<person name="Okubo K."/>
<person name="Tokunaga F."/>
<person name="Miyata T."/>
<person name="Iwanaga S."/>
<person name="Hamasaki N."/>
</authorList>
<dbReference type="PubMed" id="3372523"/>
</citation>
<scope>PROTEIN SEQUENCE OF 834-911</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1991" name="Biochim. Biophys. Acta" volume="1061" first="253" last="266">
<title>Phosphorylation sites in human erythrocyte band 3 protein.</title>
<authorList>
<person name="Yannoukakos D."/>
<person name="Vasseur C."/>
<person name="Piau J.-P."/>
<person name="Wajcman H."/>
<person name="Bursaux E."/>
</authorList>
<dbReference type="PubMed" id="1998697"/>
<dbReference type="DOI" id="10.1016/0005-2736(91)90291-f"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-8; TYR-21 AND TYR-46</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1991" name="J. Biol. Chem." volume="266" first="16420" last="16424">
<title>Palmitoylation of cysteine 69 from the COOH-terminal of band 3 protein in the human erythrocyte membrane. Acylation occurs in the middle of the consensus sequence of F--I-IICLAVL found in band 3 protein and G2 protein of Rift Valley fever virus.</title>
<authorList>
<person name="Okubo K."/>
<person name="Hamasaki N."/>
<person name="Hara K."/>
<person name="Kageura M."/>
</authorList>
<dbReference type="PubMed" id="1885574"/>
</citation>
<scope>PALMITOYLATION AT CYS-843</scope>
</reference>
<reference key="19">
<citation type="journal article" date="1995" name="J. Biol. Chem." volume="270" first="22050" last="22057">
<title>The ANK repeats of erythrocyte ankyrin form two distinct but cooperative binding sites for the erythrocyte anion exchanger.</title>
<authorList>
<person name="Michaely P."/>
<person name="Bennett V."/>
</authorList>
<dbReference type="PubMed" id="7665627"/>
<dbReference type="DOI" id="10.1074/jbc.270.37.22050"/>
</citation>
<scope>INTERACTION WITH ANK1</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2000" name="Biochem. J." volume="349" first="51" last="57">
<title>Processing of N-linked oligosaccharide depends on its location in the anion exchanger, AE1, membrane glycoprotein.</title>
<authorList>
<person name="Li J."/>
<person name="Quilty J."/>
<person name="Popov M."/>
<person name="Reithmeier R.A."/>
</authorList>
<dbReference type="PubMed" id="10861210"/>
<dbReference type="DOI" id="10.1042/0264-6021:3490051"/>
</citation>
<scope>GLYCOSYLATION AT ASN-642</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2000" name="Blood" volume="96" first="1550" last="1557">
<title>Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites.</title>
<authorList>
<person name="Brunati A.M."/>
<person name="Bordin L."/>
<person name="Clari G."/>
<person name="James P."/>
<person name="Quadroni M."/>
<person name="Baritono E."/>
<person name="Pinna L.A."/>
<person name="Donella-Deana A."/>
</authorList>
<dbReference type="PubMed" id="10942405"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-8; TYR-21; TYR-359 AND TYR-904</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2013" name="Biochim. Biophys. Acta" volume="1828" first="956" last="966">
<title>Stomatin interacts with GLUT1/SLC2A1, band 3/SLC4A1, and aquaporin-1 in human erythrocyte membrane domains.</title>
<authorList>
<person name="Rungaldier S."/>
<person name="Oberwagner W."/>
<person name="Salzer U."/>
<person name="Csaszar E."/>
<person name="Prohaska R."/>
</authorList>
<dbReference type="PubMed" id="23219802"/>
<dbReference type="DOI" id="10.1016/j.bbamem.2012.11.030"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INTERACTION WITH STOM</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2015" name="Biochem. Biophys. Res. Commun." volume="463" first="706" last="711">
<title>Transmembrane protein 139 (TMEM139) interacts with human kidney isoform of anion exchanger 1 (kAE1).</title>
<authorList>
<person name="Nuiplot N.O."/>
<person name="Junking M."/>
<person name="Duangtum N."/>
<person name="Khunchai S."/>
<person name="Sawasdee N."/>
<person name="Yenchitsomanus P.T."/>
<person name="Akkarapatumwong V."/>
</authorList>
<dbReference type="PubMed" id="26049106"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2015.05.128"/>
</citation>
<scope>INTERACTION WITH TM139</scope>
</reference>
<reference key="26">
<citation type="journal article" date="1993" name="EMBO J." volume="12" first="2233" last="2239">
<title>Two-dimensional structure of the membrane domain of human band 3, the anion transport protein of the erythrocyte membrane.</title>
<authorList>
<person name="Wang D.N."/>
<person name="Kuehlbrandt W."/>
<person name="Sarabia V.E."/>
<person name="Reithmeier R.A.F."/>
</authorList>
<dbReference type="PubMed" id="8508760"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1993.tb05876.x"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY</scope>
</reference>
<reference key="27">
<citation type="journal article" date="1994" name="EMBO J." volume="13" first="3230" last="3235">
<title>Three-dimensional map of the dimeric membrane domain of the human erythrocyte anion exchanger, Band 3.</title>
<authorList>
<person name="Wang D.N."/>
<person name="Sarabia V.E."/>
<person name="Reithmeier R.A.F."/>
<person name="Kuehlbrandt W."/>
</authorList>
<dbReference type="PubMed" id="8045253"/>
<dbReference type="DOI" id="10.1002/j.1460-2075.1994.tb06624.x"/>
</citation>
<scope>STRUCTURE BY ELECTRON MICROSCOPY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="1994" name="Eur. J. Biochem." volume="221" first="445" last="454">
<title>The solution structures of the first and second transmembrane-spanning segments of band 3.</title>
<authorList>
<person name="Gargaro A.R."/>
<person name="Bloomberg G.B."/>
<person name="Dempsey C.E."/>
<person name="Murray M."/>
<person name="Tanner M.J.A."/>
</authorList>
<dbReference type="PubMed" id="8168533"/>
<dbReference type="DOI" id="10.1111/j.1432-1033.1994.tb18757.x"/>
</citation>
<scope>STRUCTURE BY NMR OF 405-424 AND 436-456</scope>
</reference>
<reference key="29">
<citation type="journal article" date="1995" name="Biochemistry" volume="34" first="16574" last="16584">
<title>Solution structure of a band 3 peptide inhibitor bound to aldolase: a proposed mechanism for regulating binding by tyrosine phosphorylation.</title>
<authorList>
<person name="Schneider M.L."/>
<person name="Post C.B."/>
</authorList>
<dbReference type="PubMed" id="8527430"/>
<dbReference type="DOI" id="10.1021/bi00051a005"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-16</scope>
</reference>
<reference key="30">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="867" last="877">
<title>Insights into tyrosine phosphorylation control of protein-protein association from the NMR structure of a band 3 peptide inhibitor bound to glyceraldehyde-3-phosphate dehydrogenase.</title>
<authorList>
<person name="Eisenmesser E.Z."/>
<person name="Post C.B."/>
</authorList>
<dbReference type="PubMed" id="9454576"/>
<dbReference type="DOI" id="10.1021/bi971445b"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-16</scope>
</reference>
<reference key="31">
<citation type="journal article" date="1998" name="Biochem. Soc. Trans." volume="26" first="516" last="520">
<title>Studies on the structure of a transmembrane region and a cytoplasmic loop of the human red cell anion exchanger.</title>
<authorList>
<person name="Chambers E.J."/>
<person name="Askin D."/>
<person name="Bloomberg G.B."/>
<person name="Ring S.M."/>
<person name="Tanner M.J."/>
</authorList>
<dbReference type="PubMed" id="9765907"/>
<dbReference type="DOI" id="10.1042/bst0260516"/>
</citation>
<scope>STRUCTURE BY NMR OF 389-430</scope>
</reference>
<reference key="32">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="11670" last="11678">
<title>NMR solution structure of a cytoplasmic surface loop of the human red cell anion transporter, band 3.</title>
<authorList>
<person name="Askin D."/>
<person name="Bloomberg G.B."/>
<person name="Chambers E.J."/>
<person name="Tanner M.J."/>
</authorList>
<dbReference type="PubMed" id="9709005"/>
<dbReference type="DOI" id="10.1021/bi973158d"/>
</citation>
<scope>STRUCTURE BY NMR OF 803-835</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2000" name="Blood" volume="96" first="2925" last="2933">
<title>Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3.</title>
<authorList>
<person name="Zhang D."/>
<person name="Kiyatkin A."/>
<person name="Bolin J.T."/>
<person name="Low P.S."/>
</authorList>
<dbReference type="PubMed" id="11049968"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 1-379</scope>
<scope>SUBUNIT</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="33848" last="33860">
<title>A substrate access tunnel in the cytosolic domain is not an essential feature of the solute carrier 4 (SLC4) family of bicarbonate transporters.</title>
<authorList>
<person name="Shnitsar V."/>
<person name="Li J."/>
<person name="Li X."/>
<person name="Calmettes C."/>
<person name="Basu A."/>
<person name="Casey J.R."/>
<person name="Moraes T.F."/>
<person name="Reithmeier R.A."/>
</authorList>
<dbReference type="PubMed" id="24121512"/>
<dbReference type="DOI" id="10.1074/jbc.m113.511865"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.23 ANGSTROMS) OF 51-356</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>GLYCOSYLATION AT ASN-642</scope>
<scope>MUTAGENESIS OF GLU-85; ARG-283; ASN-642 AND GLU-681</scope>
<scope>CHARACTERIZATION OF VARIANT ACANTHOCYTOSIS LEU-868</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2015" name="Science" volume="350" first="680" last="684">
<title>Crystal structure of the anion exchanger domain of human erythrocyte band 3.</title>
<authorList>
<person name="Arakawa T."/>
<person name="Kobayashi-Yurugi T."/>
<person name="Alguel Y."/>
<person name="Iwanari H."/>
<person name="Hatae H."/>
<person name="Iwata M."/>
<person name="Abe Y."/>
<person name="Hino T."/>
<person name="Ikeda-Suno C."/>
<person name="Kuma H."/>
<person name="Kang D."/>
<person name="Murata T."/>
<person name="Hamakubo T."/>
<person name="Cameron A.D."/>
<person name="Kobayashi T."/>
<person name="Hamasaki N."/>
<person name="Iwata S."/>
</authorList>
<dbReference type="PubMed" id="26542571"/>
<dbReference type="DOI" id="10.1126/science.aaa4335"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.50 ANGSTROMS)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TOPOLOGY</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="1991" name="Blood" volume="78" first="1117" last="1120">
<title>Human erythrocyte band 3 polymorphism (band 3 Memphis): characterization of the structural modification (Lys 56--&gt;Glu) by protein chemistry methods.</title>
<authorList>
<person name="Yannoukakos D."/>
<person name="Vasseur C."/>
<person name="Driancourt C."/>
<person name="Blouquit Y."/>
<person name="Delauney J."/>
<person name="Wajcman H."/>
<person name="Bursaux E."/>
</authorList>
<dbReference type="PubMed" id="1678289"/>
</citation>
<scope>VARIANT MEMPHIS GLU-56</scope>
</reference>
<reference key="37">
<citation type="journal article" date="1991" name="Proc. Natl. Acad. Sci. U.S.A." volume="88" first="11022" last="11026">
<title>Deletion in erythrocyte band 3 gene in malaria-resistant Southeast Asian ovalocytosis.</title>
<authorList>
<person name="Jarolim P."/>
<person name="Palek J."/>
<person name="Amato D."/>
<person name="Hassan K."/>
<person name="Sapak P."/>
<person name="Nurse G.T."/>
<person name="Rubin H.L."/>
<person name="Zhai S."/>
<person name="Sahr K.E."/>
<person name="Liu S.-C."/>
</authorList>
<dbReference type="PubMed" id="1722314"/>
<dbReference type="DOI" id="10.1073/pnas.88.24.11022"/>
</citation>
<scope>VARIANT SAO 400-ALA--ALA-408 DEL</scope>
<scope>VARIANT MEMPHIS GLU-56</scope>
</reference>
<reference key="38">
<citation type="journal article" date="1992" name="Blood" volume="80" first="523" last="529">
<title>Band 3 Tuscaloosa: Pro-327--&gt;Arg substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4.2.</title>
<authorList>
<person name="Jarolim P."/>
<person name="Palek J."/>
<person name="Rubin H.L."/>
<person name="Prchal J.T."/>
<person name="Korsgren C."/>
<person name="Cohen C.M."/>
</authorList>
<dbReference type="PubMed" id="1378323"/>
</citation>
<scope>VARIANT SPH4 ARG-327</scope>
</reference>
<reference key="39">
<citation type="journal article" date="1992" name="J. Mol. Biol." volume="223" first="949" last="958">
<title>Basis of unique red cell membrane properties in hereditary ovalocytosis.</title>
<authorList>
<person name="Schofield A.E."/>
<person name="Tanner M.J.A."/>
<person name="Pinder J.C."/>
<person name="Clough B."/>
<person name="Bayley P.M."/>
<person name="Nash G.B."/>
<person name="Dluzewski A.R."/>
<person name="Reardon D.M."/>
<person name="Cox T.M."/>
<person name="Wilson R.J.M."/>
<person name="Gratzer W.B."/>
</authorList>
<dbReference type="PubMed" id="1538405"/>
<dbReference type="DOI" id="10.1016/0022-2836(92)90254-h"/>
</citation>
<scope>VARIANT SAO 400-ALA--ALA-408 DEL</scope>
<scope>CHARACTERIZATION OF VARIANT SAO 400-ALA--ALA-408 DEL</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="40">
<citation type="journal article" date="1993" name="Biochem. J." volume="293" first="317" last="320">
<title>Band 3 HT, a human red-cell variant associated with acanthocytosis and increased anion transport, carries the mutation Pro-868--&gt;Leu in the membrane domain of band 3.</title>
<authorList>
<person name="Bruce L.J."/>
<person name="Kay M.M."/>
<person name="Lawrence C."/>
<person name="Tanner M.J."/>
</authorList>
<dbReference type="PubMed" id="8343110"/>
<dbReference type="DOI" id="10.1042/bj2930317"/>
</citation>
<scope>VARIANT ACANTHOCYTOSIS LEU-868</scope>
</reference>
<reference key="41">
<citation type="journal article" date="1993" name="Blood" volume="81" first="2155" last="2165">
<title>Human erythrocyte protein 4.2 deficiency associated with hemolytic anemia and a homozygous 40 glutamic acid--&gt;lysine substitution in the cytoplasmic domain of band 3 (band 3Montefiore).</title>
<authorList>
<person name="Rybicki A.C."/>
<person name="Qiu J.J.H."/>
<person name="Musto S."/>
<person name="Rosen N.L."/>
<person name="Nagel R.L."/>
<person name="Schwartz R.S."/>
</authorList>
<dbReference type="PubMed" id="8471774"/>
</citation>
<scope>VARIANT LYS-40</scope>
</reference>
<reference key="42">
<citation type="journal article" date="1994" name="J. Biol. Chem." volume="269" first="16155" last="16158">
<title>Band 3 Memphis variant II. Altered stilbene disulfonate binding and the Diego (Dia) blood group antigen are associated with the human erythrocyte band 3 mutation Pro-854--&gt;Leu.</title>
<authorList>
<person name="Bruce L.J."/>
<person name="Anstee D.J."/>
<person name="Spring F.A."/>
<person name="Tanner M.J."/>
</authorList>
<dbReference type="PubMed" id="8206915"/>
</citation>
<scope>VARIANTS BLOOD GROUP DI(A)/MEMPHIS-II GLU-56 AND LEU-854</scope>
</reference>
<reference key="43">
<citation type="journal article" date="1995" name="Blood" volume="85" first="541" last="547">
<title>Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of interaction between band 3 and glycophorin A under certain conditions.</title>
<authorList>
<person name="Bruce L.J."/>
<person name="Ring S.M."/>
<person name="Anstee D.J."/>
<person name="Reid M.E."/>
<person name="Wilkinson S."/>
<person name="Tanner M.J."/>
</authorList>
<dbReference type="PubMed" id="7812009"/>
</citation>
<scope>VARIANT BLOOD GROUP WR(A) LYS-658</scope>
</reference>
<reference key="44">
<citation type="journal article" date="1995" name="Blood" volume="85" first="634" last="640">
<title>Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis.</title>
<authorList>
<person name="Jarolim P."/>
<person name="Rubin H.L."/>
<person name="Brabec V."/>
<person name="Chrobak L."/>
<person name="Zolotarev A.S."/>
<person name="Alper S.L."/>
<person name="Brugnara C."/>
<person name="Wichterle H."/>
<person name="Palek J."/>
</authorList>
<dbReference type="PubMed" id="7530501"/>
</citation>
<scope>VARIANTS SPH4 GLN-760; TRP-760; CYS-808 AND TRP-870</scope>
</reference>
<reference key="45">
<citation type="journal article" date="1996" name="Blood" volume="88" first="4366" last="4374">
<title>Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency.</title>
<authorList>
<person name="Jarolim P."/>
<person name="Murray J.L."/>
<person name="Rubin H.L."/>
<person name="Taylor W.M."/>
<person name="Prchal J.T."/>
<person name="Ballas S.K."/>
<person name="Snyder L.M."/>
<person name="Chrobak L."/>
<person name="Melrose W.D."/>
<person name="Brabec V."/>
<person name="Palek J."/>
</authorList>
<dbReference type="PubMed" id="8943874"/>
</citation>
<scope>VARIANTS SPH4 ASP-285; GLU-455; PRO-707; PRO-834 AND MET-837</scope>
</reference>
<reference key="46">
<citation type="journal article" date="1996" name="Nat. Genet." volume="13" first="214" last="218">
<title>Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis.</title>
<authorList>
<person name="Eber S.W."/>
<person name="Gonzalez J.M."/>
<person name="Lux M.L."/>
<person name="Scarpa A.L."/>
<person name="Tse W.T."/>
<person name="Dornwell M."/>
<person name="Herbers J."/>
<person name="Kugler W."/>
<person name="Oezcan R."/>
<person name="Pekrun A."/>
<person name="Gallagher P.G."/>
<person name="Schroeter W."/>
<person name="Forget B.G."/>
<person name="Lux S.E."/>
</authorList>
<dbReference type="PubMed" id="8640229"/>
<dbReference type="DOI" id="10.1038/ng0696-214"/>
</citation>
<scope>VARIANTS SPH4 CYS-518 AND MET-663 DEL</scope>
<scope>VARIANT LYS-40</scope>
</reference>
<reference key="47">
<citation type="journal article" date="1997" name="Blood" volume="90" first="414" last="420">
<title>Modulation of clinical expression and band 3 deficiency in hereditary spherocytosis.</title>
<authorList>
<person name="Alloisio N."/>
<person name="Texier P."/>
<person name="Vallier A."/>
<person name="Ribeiro M.L."/>
<person name="Morle L."/>
<person name="Bozon M."/>
<person name="Bursaux E."/>
<person name="Maillet P."/>
<person name="Goncalves P."/>
<person name="Tanner M.J."/>
<person name="Tamagnini G."/>
<person name="Delaunay J."/>
</authorList>
<dbReference type="PubMed" id="9207478"/>
</citation>
<scope>VARIANTS SPH4 SER-147 AND MET-488</scope>
</reference>
<reference key="48">
<citation type="journal article" date="1997" name="Br. J. Haematol." volume="96" first="70" last="76">
<title>Novel band 3 variants (bands 3 Foggia, Napoli I and Napoli II) associated with hereditary spherocytosis and band 3 deficiency: status of the D38A polymorphism within the EPB3 locus.</title>
<authorList>
<person name="Miraglia del Giudice E."/>
<person name="Vallier A."/>
<person name="Maillet P."/>
<person name="Perrotta S."/>
<person name="Cutillo S."/>
<person name="Iolascon A."/>
<person name="Tanner M.J."/>
<person name="Delaunay J."/>
<person name="Alloisio N."/>
</authorList>
<dbReference type="PubMed" id="9012689"/>
<dbReference type="DOI" id="10.1046/j.1365-2141.1997.8732504.x"/>
</citation>
<scope>VARIANT SPH4 ASN-783</scope>
<scope>VARIANTS ALA-38 AND MET-73</scope>
</reference>
<reference key="49">
<citation type="journal article" date="1997" name="Br. J. Haematol." volume="98" first="32" last="40">
<title>Heterogenous band 3 deficiency in hereditary spherocytosis related to different band 3 gene defects.</title>
<authorList>
<person name="Dhermy D."/>
<person name="Galand C."/>
<person name="Bournier O."/>
<person name="Boulanger L."/>
<person name="Cynober T."/>
<person name="Schismanoff P.O."/>
<person name="Bursaux E."/>
<person name="Tchernia G."/>
<person name="Boivin P."/>
<person name="Garbarz M."/>
</authorList>
<dbReference type="PubMed" id="9233560"/>
<dbReference type="DOI" id="10.1046/j.1365-2141.1997.1893005.x"/>
</citation>
<scope>VARIANTS SPH4 CYS-490 AND MET-837</scope>
</reference>
<reference key="50">
<citation type="journal article" date="1997" name="Br. J. Haematol." volume="99" first="474" last="474">
<authorList>
<person name="Dhermy D."/>
<person name="Galand C."/>
<person name="Bournier O."/>
<person name="Boulanger L."/>
<person name="Cynober T."/>
<person name="Schismanoff P.O."/>
<person name="Bursaux E."/>
<person name="Tchernia G."/>
<person name="Boivin P."/>
<person name="Garbarz M."/>
</authorList>
</citation>
<scope>ERRATUM OF PUBMED:9233560</scope>
</reference>
<reference key="51">
<citation type="journal article" date="1997" name="J. Clin. Invest." volume="100" first="1693" last="1707">
<title>Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (Band 3, AE1) gene.</title>
<authorList>
<person name="Bruce L.J."/>
<person name="Cope D.L."/>
<person name="Jones G.K."/>
<person name="Schofield A.E."/>
<person name="Burley M."/>
<person name="Povey S."/>
<person name="Unwin R.J."/>
<person name="Wrong O."/>
<person name="Tanner M.J."/>
</authorList>
<dbReference type="PubMed" id="9312167"/>
<dbReference type="DOI" id="10.1172/jci119694"/>
</citation>
<scope>VARIANTS AD-DRTA CYS-589; HIS-589 AND PHE-613</scope>
</reference>
<reference key="52">
<citation type="journal article" date="1997" name="Transfusion" volume="37" first="607" last="615">
<title>Blood group antigens Rb(a), Tr(a), and Wd(a) are located in the third ectoplasmic loop of erythroid band 3.</title>
<authorList>
<person name="Jarolim P."/>
<person name="Murray J.L."/>
<person name="Rubin H.L."/>
<person name="Smart E."/>
<person name="Moulds J.M."/>
</authorList>
<dbReference type="PubMed" id="9191821"/>
<dbReference type="DOI" id="10.1046/j.1537-2995.1997.37697335155.x"/>
</citation>
<scope>VARIANTS BLOOD GROUPS RB(A); TR(A) AND WD(A)</scope>
</reference>
<reference key="53">
<citation type="journal article" date="1998" name="Acta Haematol." volume="100" first="200" last="203">
<title>Band 3 Tokyo: Thr837--&gt;Ala837 substitution in erythrocyte band 3 protein associated with spherocytic hemolysis.</title>
<authorList>
<person name="Iwase S."/>
<person name="Ideguchi H."/>
<person name="Takao M."/>
<person name="Horiguchi-Yamada J."/>
<person name="Iwasaki M."/>
<person name="Takahara S."/>
<person name="Sekikawa T."/>
<person name="Mochizuki S."/>
<person name="Yamada H."/>
</authorList>
<dbReference type="PubMed" id="9973643"/>
<dbReference type="DOI" id="10.1159/000040904"/>
</citation>
<scope>VARIANT SPH4 ALA-837</scope>
</reference>
<reference key="54">
<citation type="journal article" date="1998" name="Blood" volume="92" first="4836" last="4843">
<title>Characterization of seven low incidence blood group antigens carried by erythrocyte band 3 protein.</title>
<authorList>
<person name="Jarolim P."/>
<person name="Rubin H.L."/>
<person name="Zakova D."/>
<person name="Storry J."/>
<person name="Reid M.E."/>
</authorList>
<dbReference type="PubMed" id="9845551"/>
</citation>
<scope>VARIANTS BLOOD GROUPS BOW; BP(A); ELO; HG(A); MO(A); VG(A) AND WU</scope>
</reference>
<reference key="55">
<citation type="journal article" date="1998" name="J. Clin. Invest." volume="102" first="2173" last="2179">
<title>Novel AE1 mutations in recessive distal renal tubular acidosis: loss-of-function is rescued by glycophorin A.</title>
<authorList>
<person name="Tanphaichitr V.S."/>
<person name="Sumboonnanonda A."/>
<person name="Ideguchi H."/>
<person name="Shayakul C."/>
<person name="Brugnara C."/>
<person name="Takao M."/>
<person name="Veerakul G."/>
<person name="Alper S.L."/>
</authorList>
<dbReference type="PubMed" id="9854053"/>
<dbReference type="DOI" id="10.1172/jci4836"/>
</citation>
<scope>VARIANT DRTA-HA ASP-701</scope>
</reference>
<reference key="56">
<citation type="journal article" date="1998" name="Proc. Natl. Acad. Sci. U.S.A." volume="95" first="6337" last="6342">
<title>Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis.</title>
<authorList>
<person name="Karet F.E."/>
<person name="Gainza F.J."/>
<person name="Gyory A.Z."/>
<person name="Unwin R.J."/>
<person name="Wrong O."/>
<person name="Tanner M.J.A."/>
<person name="Nayir A."/>
<person name="Alpay H."/>
<person name="Santos F."/>
<person name="Hulton S.A."/>
<person name="Bakkaloglu A."/>
<person name="Ozen S."/>
<person name="Cunningham M.J."/>
<person name="di Pietro A."/>
<person name="Walker W.G."/>
<person name="Lifton R.P."/>
</authorList>
<dbReference type="PubMed" id="9600966"/>
<dbReference type="DOI" id="10.1073/pnas.95.11.6337"/>
</citation>
<scope>VARIANTS AD-DRTA HIS-589 AND SER-589</scope>
</reference>
<reference key="57">
<citation type="journal article" date="1998" name="Transfusion" volume="38" first="745" last="748">
<title>A Gly565--&gt;Ala substitution in human erythroid band 3 accounts for the Wu blood group polymorphism.</title>
<authorList>
<person name="Zelinski T."/>
<person name="McManus K."/>
<person name="Punter F."/>
<person name="Moulds M."/>
<person name="Coghlan G."/>
</authorList>
<dbReference type="PubMed" id="9709782"/>
<dbReference type="DOI" id="10.1046/j.1537-2995.1998.38898375513.x"/>
</citation>
<scope>VARIANTS BLOOD GROUP WU</scope>
</reference>
<reference key="58">
<citation type="journal article" date="1999" name="Eur. J. Haematol." volume="63" first="360" last="361">
<title>Arginine 490 is a hot spot for mutation in the band 3 gene in hereditary spherocytosis.</title>
<authorList>
<person name="Lima P.R.M."/>
<person name="Sales T.S.I."/>
<person name="Costa F.F."/>
<person name="Saad S.T.O."/>
</authorList>
<dbReference type="PubMed" id="10580570"/>
<dbReference type="DOI" id="10.1111/j.1600-0609.1999.tb01141.x"/>
</citation>
<scope>VARIANT SPH4 HIS-490</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2000" name="Biochem. J." volume="350" first="41" last="51">
<title>Band 3 mutations, renal tubular acidosis and South-East Asian ovalocytosis in Malaysia and Papua New Guinea: loss of up to 95% band 3 transport in red cells.</title>
<authorList>
<person name="Bruce L.J."/>
<person name="Wrong O."/>
<person name="Toye A.M."/>
<person name="Young M.T."/>
<person name="Ogle G."/>
<person name="Ismail Z."/>
<person name="Sinha A.K."/>
<person name="McMaster P."/>
<person name="Hwaihwanje I."/>
<person name="Nash G.B."/>
<person name="Hart S."/>
<person name="Lavu E."/>
<person name="Palmer R."/>
<person name="Othman A."/>
<person name="Unwin R.J."/>
<person name="Tanner M.J.A."/>
</authorList>
<dbReference type="PubMed" id="10926824"/>
<dbReference type="DOI" id="10.1042/bj3500041"/>
</citation>
<scope>VARIANTS DRTA-HA ASP-701 AND VAL-850 DEL</scope>
<scope>VARIANT AD-DRTA ASP-858</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2000" name="Blood" volume="96" first="1602" last="1604">
<title>Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3.</title>
<authorList>
<person name="Ribeiro M.L."/>
<person name="Alloisio N."/>
<person name="Almeida H."/>
<person name="Gomes C."/>
<person name="Texier P."/>
<person name="Lemos C."/>
<person name="Mimoso G."/>
<person name="Morle L."/>
<person name="Bey-Cabet F."/>
<person name="Rudigoz R.-C."/>
<person name="Delaunay J."/>
<person name="Tamagnini G."/>
</authorList>
<dbReference type="PubMed" id="10942416"/>
</citation>
<scope>VARIANT SPH4 MET-488</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2000" name="Int. J. Hematol." volume="71" first="118" last="135">
<title>Characteristic features of the genotype and phenotype of hereditary spherocytosis in the Japanese population.</title>
<authorList>
<person name="Yawata Y."/>
<person name="Kanzaki A."/>
<person name="Yawata A."/>
<person name="Doerfler W."/>
<person name="Oezcan R."/>
<person name="Eber S.W."/>
</authorList>
<dbReference type="PubMed" id="10745622"/>
</citation>
<scope>VARIANTS SPH4 ARG-130; ARG-455; ARG-714; TRP-760; GLN-760; HIS-808; ARG-837 AND MET-837</scope>
<scope>VARIANTS ALA-38; GLU-56; ASP-72 AND LEU-854</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2000" name="Traffic" volume="1" first="987" last="998">
<title>Trafficking and folding defects in hereditary spherocytosis mutants of the human red cell anion exchanger.</title>
<authorList>
<person name="Quilty J.A."/>
<person name="Reithmeier R.A."/>
</authorList>
<dbReference type="PubMed" id="11208088"/>
<dbReference type="DOI" id="10.1034/j.1600-0854.2000.011208.x"/>
</citation>
<scope>CHARACTERIZATION OF VARIANTS PRO-707; GLN-760; TRP-760; CYS-808; PRO-834; MET-837 AND TRP-870</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2000" name="Transfusion" volume="40" first="325" last="329">
<title>Amino acid substitutions in human erythroid protein band 3 account for the low-incidence antigens NFLD and BOW.</title>
<authorList>
<person name="McManus K."/>
<person name="Pongoski J."/>
<person name="Coghlan G."/>
<person name="Zelinski T."/>
</authorList>
<dbReference type="PubMed" id="10738034"/>
<dbReference type="DOI" id="10.1046/j.1537-2995.2000.40030325.x"/>
</citation>
<scope>VARIANTS BLOOD GROUP NFLD+ ASP-429 AND ALA-561</scope>
<scope>VARIANT BLOOD GROUP BOW+ SER-561</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2000" name="Transfusion" volume="40" first="1246" last="1249">
<title>An amino acid substitution in the putative second extracellular loop of RBC band 3 accounts for the Froese blood group polymorphism.</title>
<authorList>
<person name="McManus K."/>
<person name="Lupe K."/>
<person name="Coghlan G."/>
<person name="Zelinski T."/>
</authorList>
<dbReference type="PubMed" id="11061863"/>
<dbReference type="DOI" id="10.1046/j.1537-2995.2000.40101246.x"/>
</citation>
<scope>VARIANT BLOOD GROUP FR(A+) LYS-480</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2000" name="Vox Sang." volume="79" first="215" last="218">
<title>Distinctive Swann blood group genotypes: molecular investigations.</title>
<authorList>
<person name="Zelinski T."/>
<person name="Rusnak A."/>
<person name="McManus K."/>
<person name="Coghlan G."/>
</authorList>
<dbReference type="PubMed" id="11155072"/>
<dbReference type="DOI" id="10.1159/000056733"/>
</citation>
<scope>VARIANTS BLOOD GROUP SW(A+) GLN-646 AND TRP-646</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2001" name="Br. J. Haematol." volume="113" first="689" last="693">
<title>Band 3 Cape Town (E90K) causes severe hereditary spherocytosis in combination with band 3 Prague III.</title>
<authorList>
<person name="Bracher N.A."/>
<person name="Lyons C.A."/>
<person name="Wessels G."/>
<person name="Mansvelt E."/>
<person name="Coetzer T.L."/>
</authorList>
<dbReference type="PubMed" id="11380459"/>
<dbReference type="DOI" id="10.1046/j.1365-2141.2001.02800.x"/>
</citation>
<scope>VARIANTS SPH4 LYS-90 AND TRP-870</scope>
</reference>
<reference key="67">
<citation type="journal article" date="2004" name="Am. J. Kidney Dis." volume="44" first="64" last="70">
<title>Novel compound heterozygous SLC4A1 mutations in Thai patients with autosomal recessive distal renal tubular acidosis.</title>
<authorList>
<person name="Sritippayawan S."/>
<person name="Sumboonnanonda A."/>
<person name="Vasuvattakul S."/>
<person name="Keskanokwong T."/>
<person name="Sawasdee N."/>
<person name="Paemanee A."/>
<person name="Thuwajit P."/>
<person name="Wilairat P."/>
<person name="Nimmannit S."/>
<person name="Malasit P."/>
<person name="Yenchitsomanus P.T."/>
</authorList>
<dbReference type="PubMed" id="15211439"/>
<dbReference type="DOI" id="10.1053/j.ajkd.2004.03.033"/>
</citation>
<scope>VARIANT DRTA-HA HIS-602</scope>
<scope>VARIANTS DRTA-NRC ASP-701 AND PRO-773</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="13833" last="13838">
<title>A novel missense mutation in AE1 causing autosomal dominant distal renal tubular acidosis retains normal transport function but is mistargeted in polarized epithelial cells.</title>
<authorList>
<person name="Rungroj N."/>
<person name="Devonald M.A.J."/>
<person name="Cuthbert A.W."/>
<person name="Reimann F."/>
<person name="Akkarapatumwong V."/>
<person name="Yenchitsomanus P.-T."/>
<person name="Bennett W.M."/>
<person name="Karet F.E."/>
</authorList>
<dbReference type="PubMed" id="14734552"/>
<dbReference type="DOI" id="10.1074/jbc.m400188200"/>
</citation>
<scope>VARIANT AD-DRTA ARG-609</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>CHARACTERIZATION OF VARIANT AD-DRTA ARG-609</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2005" name="Eur. J. Haematol." volume="74" first="396" last="401">
<title>Band 3Tambau: a de novo mutation in the AE1 gene associated with hereditary spherocytosis. Implications for anion exchange and insertion into the red blood cell membrane.</title>
<authorList>
<person name="Lima P.R.M."/>
<person name="Baratti M.O."/>
<person name="Chiattone M.L."/>
<person name="Costa F.F."/>
<person name="Saad S.T.O."/>
</authorList>
<dbReference type="PubMed" id="15813913"/>
<dbReference type="DOI" id="10.1111/j.1600-0609.2004.00405.x"/>
</citation>
<scope>VARIANT SPH4 LYS-663</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2005" name="Nat. Genet." volume="37" first="1258" last="1263">
<title>Monovalent cation leaks in human red cells caused by single amino-acid substitutions in the transport domain of the band 3 chloride-bicarbonate exchanger, AE1.</title>
<authorList>
<person name="Bruce L.J."/>
<person name="Robinson H.C."/>
<person name="Guizouarn H."/>
<person name="Borgese F."/>
<person name="Harrison P."/>
<person name="King M.-J."/>
<person name="Goede J.S."/>
<person name="Coles S.E."/>
<person name="Gore D.M."/>
<person name="Lutz H.U."/>
<person name="Ficarella R."/>
<person name="Layton D.M."/>
<person name="Iolascon A."/>
<person name="Ellory J.C."/>
<person name="Stewart G.W."/>
</authorList>
<dbReference type="PubMed" id="16227998"/>
<dbReference type="DOI" id="10.1038/ng1656"/>
</citation>
<scope>INVOLVEMENT IN CHC AND SPH4</scope>
<scope>VARIANT GLU-56</scope>
<scope>VARIANTS CHC PRO-687; PRO-731 AND ARG-734</scope>
<scope>VARIANTS SPH4 TYR-705 AND GLN-760</scope>
<scope>CHARACTERIZATION OF VARIANTS CHC PRO-687; PRO-731 AND ARG-734</scope>
<scope>CHARACTERIZATION OF VARIANTS SPH4 TYR-705 AND GLN-760</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2010" name="Mol. Membr. Biol." volume="27" first="92" last="103">
<title>Impaired trafficking and intracellular retention of mutant kidney anion exchanger 1 proteins (G701D and A858D) associated with distal renal tubular acidosis.</title>
<authorList>
<person name="Ungsupravate D."/>
<person name="Sawasdee N."/>
<person name="Khositseth S."/>
<person name="Udomchaiprasertkul W."/>
<person name="Khoprasert S."/>
<person name="Li J."/>
<person name="Reithmeier R.A."/>
<person name="Yenchitsomanus P.T."/>
</authorList>
<dbReference type="PubMed" id="20151848"/>
<dbReference type="DOI" id="10.3109/09687681003588020"/>
</citation>
<scope>CHARACTERIZATION OF VARIANT DRTA-HA ASP-701</scope>
<scope>CHARACTERIZATION OF VARIANT AD-DRTA ASP-858</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2011" name="Am. J. Physiol." volume="301" first="C1325" last="C1343">
<title>Loss-of-function and gain-of-function phenotypes of stomatocytosis mutant RhAG F65S.</title>
<authorList>
<person name="Stewart A.K."/>
<person name="Shmukler B.E."/>
<person name="Vandorpe D.H."/>
<person name="Rivera A."/>
<person name="Heneghan J.F."/>
<person name="Li X."/>
<person name="Hsu A."/>
<person name="Karpatkin M."/>
<person name="O'Neill A.F."/>
<person name="Bauer D.E."/>
<person name="Heeney M.M."/>
<person name="John K."/>
<person name="Kuypers F.A."/>
<person name="Gallagher P.G."/>
<person name="Lux S.E."/>
<person name="Brugnara C."/>
<person name="Westhoff C.M."/>
<person name="Alper S.L."/>
</authorList>
<dbReference type="PubMed" id="21849667"/>
<dbReference type="DOI" id="10.1152/ajpcell.00054.2011"/>
</citation>
<scope>VARIANT ILE-862</scope>
</reference>
<comment type="function">
<text evidence="11 20 22 31 34">Functions both as a transporter that mediates electroneutral anion exchange across the cell membrane and as a structural protein. Major integral membrane glycoprotein of the erythrocyte membrane; required for normal flexibility and stability of the erythrocyte membrane and for normal erythrocyte shape via the interactions of its cytoplasmic domain with cytoskeletal proteins, glycolytic enzymes, and hemoglobin. Functions as a transporter that mediates the 1:1 exchange of inorganic anions across the erythrocyte membrane. Mediates chloride-bicarbonate exchange in the kidney, and is required for normal acidification of the urine.</text>
</comment>
<comment type="activity regulation">
<text>Phenyl isothiocyanate inhibits anion transport in vitro.</text>
</comment>
<comment type="subunit">
<text evidence="14 31 33 35 41">A dimer in solution, but in its membrane environment, it exists primarily as a mixture of dimers and tetramers and spans the membrane asymmetrically. Interacts (via cytoplasmic N-terminal domain) with ANK1 (via N-terminal ANK repeats); tetramer formation is critical for ankyrin association. Interacts with STOM. Isoform 2 interacts with TM139 (PubMed:26049106).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-10225815">
<id>Q08AM2</id>
<label>ADAM33</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-714630">
<id>P05026</id>
<label>ATP1B1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-3922513">
<id>O95393</id>
<label>BMP10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-11579371">
<id>Q9BXR6</id>
<label>CFHR5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-702665">
<id>P02724</id>
<label>GYPA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-1211440">
<id>P27105</id>
<label>STOM</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>14</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-2852148">
<id>Q9H2L4</id>
<label>TMEM60</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-2750726">
<id>P46406</id>
<label>GAPDH</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-7576138">
<id>P02730</id>
</interactant>
<interactant intactId="EBI-11621504">
<id>A5K5E5</id>
<label>PVX_088820</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="11 34 36 39">Cell membrane</location>
<topology evidence="36">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="39">Basolateral cell membrane</location>
<topology evidence="39">Multi-pass membrane protein</topology>
</subcellularLocation>
<text evidence="39">Detected in the erythrocyte cell membrane and on the basolateral membrane of alpha-intercalated cells in the collecting duct in the kidney.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P02730-1</id>
<name>1</name>
<name>eAE1</name>
<name>Erythrocyte</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P02730-2</id>
<name evidence="39">2</name>
<name>kAE1</name>
<name>Kidney</name>
<sequence type="described" ref="VSP_057833"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="11 22 33 36 39">Detected in erythrocytes (at protein level) (PubMed:7506871, PubMed:26542571). Isoform 2 is expressed in kidney (at protein level) (PubMed:7506871).</text>
</comment>
<comment type="PTM">
<text evidence="12 30">Phosphorylated on Tyr-8 and Tyr-21 most likely by SYK. PP1-resistant phosphorylation that precedes Tyr-359 and Tyr-904 phosphorylation.</text>
</comment>
<comment type="PTM">
<text evidence="12 30">Phosphorylated on Tyr-359 and Tyr-904 most likely by LYN. PP1-inhibited phosphorylation that follows Tyr-8 and Tyr-21 phosphorylation.</text>
</comment>
<comment type="PTM">
<text evidence="36">N-glycosylated.</text>
</comment>
<comment type="polymorphism">
<text>SLC4A1 is responsible for the Diego blood group system [MIM:110500]. The molecular basis of the Di(a)=Di1/Di(b)/Di2 blood group antigens is a single variation in position 854; Leu-854 corresponds to Di(a) and Pro-854 to Di(b). The molecular basis of the Wr(a)=Di3/Wr(b)/Di4 blood group antigens is a single variation in position 658; Lys-658 corresponds to Wr(a) and Glu-658 to Wr(b). The blood group antigens Wd(a)=Di5 (Waldner-type) has Met-557; Rb(a)=Di6 has Leu-548 and WARR=Di7 has Ile-552.</text>
</comment>
<comment type="polymorphism">
<text>SLC4A1 is responsible for the Swann blood group system (SW) [MIM:601550]. Sw(a+) has a Gln or a Trp at position 646 and Sw(a-) has an Arg.</text>
</comment>
<comment type="polymorphism">
<text>SLC4A1 is responsible for the Froese blood group system (FR) [MIM:601551]. FR(a+) has a Lys at position 480 and FR(a-) has a Glu.</text>
</comment>
<comment type="polymorphism">
<text>Genetic variations in SLC4A1 are involved in resistance to malaria [MIM:611162].</text>
</comment>
<comment type="disease" evidence="22 28">
<disease id="DI-00448">
<name>Ovalocytosis, Southeast Asian</name>
<acronym>SAO</acronym>
<description>A hereditary hematologic disorder characterized by ovalocytic erythrocytes that are rigid and exhibit reduced expression of many erythrocyte antigens. Clinical manifestations include mild hemolysis, intermittent jaundice and gallstones. However, the disorder is most often asymptomatic.</description>
<dbReference type="MIM" id="166900"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="7 9 13 18 19 24 25 40 46 47 48 49 50 51 55">
<disease id="DI-02324">
<name>Spherocytosis 4</name>
<acronym>SPH4</acronym>
<description>Spherocytosis is a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal.</description>
<dbReference type="MIM" id="612653"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease">
<disease id="DI-01207">
<name>Renal tubular acidosis, distal, autosomal dominant</name>
<acronym>AD-dRTA</acronym>
<description>An autosomal dominant disease characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha-intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification.</description>
<dbReference type="MIM" id="179800"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="11 21 54">
<disease id="DI-01237">
<name>Renal tubular acidosis, distal, with hemolytic anemia</name>
<acronym>dRTA-HA</acronym>
<description>A disease characterized by the association of hemolytic anemia with distal renal tubular acidosis, the reduced ability to acidify urine resulting in variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis.</description>
<dbReference type="MIM" id="611590"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21">
<disease id="DI-03438">
<name>Renal tubular acidosis, distal, with normal red cell morphology</name>
<acronym>dRTA-NRC</acronym>
<description>A disease characterized by reduced ability to acidify urine, variable hyperchloremic hypokalemic metabolic acidosis, nephrocalcinosis, and nephrolithiasis. It is due to functional failure of alpha-intercalated cells of the cortical collecting duct of the distal nephron, where vectorial proton transport is required for urinary acidification.</description>
<dbReference type="MIM" id="611590"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="25">
<disease id="DI-04609">
<name>Cryohydrocytosis</name>
<acronym>CHC</acronym>
<description>An autosomal dominant disorder of red cell membrane permeability characterized by cold-induced changes in cell volume, resulting in cold-sensitive stomatocytosis, and increased erythrocyte osmotic fragility and autohemolysis at 4 degrees Celsius. Patients present with mild to moderate hemolytic anemia, splenomegaly, fatigue, and pseudohyperkalemia due to a potassium leak from the erythrocytes.</description>
<dbReference type="MIM" id="185020"/>
</disease>
<text>The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="57">Belongs to the anion exchanger (TC 2.A.31) family.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Band_3"/>
<text>Band 3 entry</text>
</comment>
<comment type="online information" name="dbRBC/BGMUT">
<link uri="https://www.ncbi.nlm.nih.gov/gv/mhc/xslcgi.cgi?cmd=bgmut/systems_info&amp;system=diego"/>
<text>Blood group antigen gene mutation database</text>
</comment>
<comment type="online information" name="SeattleSNPs">
<link uri="http://pga.gs.washington.edu/data/slc4a1/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/SLC4A1ID42325ch17q21.html"/>
</comment>
<dbReference type="EMBL" id="X12609">
<property type="protein sequence ID" value="CAA31128.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M27819">
<property type="protein sequence ID" value="AAA35514.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ419529">
<property type="protein sequence ID" value="ABD74692.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GQ981383">
<property type="protein sequence ID" value="ADN39420.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="GQ981384">
<property type="protein sequence ID" value="ADN39421.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="DQ072115">
<property type="protein sequence ID" value="AAY57324.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471178">
<property type="protein sequence ID" value="EAW51614.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC096106">
<property type="protein sequence ID" value="AAH96106.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC096107">
<property type="protein sequence ID" value="AAH96107.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC099628">
<property type="protein sequence ID" value="AAH99628.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC099629">
<property type="protein sequence ID" value="AAH99629.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC101570">
<property type="protein sequence ID" value="AAI01571.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC101574">
<property type="protein sequence ID" value="AAI01575.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S68680">
<property type="protein sequence ID" value="AAC60608.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11481.1">
<molecule id="P02730-1"/>
</dbReference>
<dbReference type="PIR" id="A36218">
<property type="entry name" value="B3HU"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000333.1">
<molecule id="P02730-1"/>
<property type="nucleotide sequence ID" value="NM_000342.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_005257650.1">
<molecule id="P02730-2"/>
<property type="nucleotide sequence ID" value="XM_005257593.4"/>
</dbReference>
<dbReference type="PDB" id="1BH7">
<property type="method" value="NMR"/>
<property type="chains" value="A=803-835"/>
</dbReference>
<dbReference type="PDB" id="1BNX">
<property type="method" value="NMR"/>
<property type="chains" value="A=389-430"/>
</dbReference>
<dbReference type="PDB" id="1BTQ">
<property type="method" value="NMR"/>
<property type="chains" value="A=405-424"/>
</dbReference>
<dbReference type="PDB" id="1BTR">
<property type="method" value="NMR"/>
<property type="chains" value="A=405-424"/>
</dbReference>
<dbReference type="PDB" id="1BTS">
<property type="method" value="NMR"/>
<property type="chains" value="A=436-456"/>
</dbReference>
<dbReference type="PDB" id="1BTT">
<property type="method" value="NMR"/>
<property type="chains" value="A=436-456"/>
</dbReference>
<dbReference type="PDB" id="1BZK">
<property type="method" value="NMR"/>
<property type="chains" value="A=389-430"/>
</dbReference>
<dbReference type="PDB" id="1HYN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="P/Q/R/S=1-379"/>
</dbReference>
<dbReference type="PDB" id="2BTA">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-15"/>
</dbReference>
<dbReference type="PDB" id="2BTB">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-15"/>
</dbReference>
<dbReference type="PDB" id="3BTB">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-15"/>
</dbReference>
<dbReference type="PDB" id="4KY9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A/P=51-356"/>
</dbReference>
<dbReference type="PDB" id="4YZF">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/B/C/D=1-911"/>
</dbReference>
<dbReference type="PDBsum" id="1BH7"/>
<dbReference type="PDBsum" id="1BNX"/>
<dbReference type="PDBsum" id="1BTQ"/>
<dbReference type="PDBsum" id="1BTR"/>
<dbReference type="PDBsum" id="1BTS"/>
<dbReference type="PDBsum" id="1BTT"/>
<dbReference type="PDBsum" id="1BZK"/>
<dbReference type="PDBsum" id="1HYN"/>
<dbReference type="PDBsum" id="2BTA"/>
<dbReference type="PDBsum" id="2BTB"/>
<dbReference type="PDBsum" id="3BTB"/>
<dbReference type="PDBsum" id="4KY9"/>
<dbReference type="PDBsum" id="4YZF"/>
<dbReference type="SMR" id="P02730"/>
<dbReference type="BioGRID" id="112412">
<property type="interactions" value="21"/>
</dbReference>
<dbReference type="CORUM" id="P02730"/>
<dbReference type="DIP" id="DIP-42428N"/>
<dbReference type="ELM" id="P02730"/>
<dbReference type="IntAct" id="P02730">
<property type="interactions" value="29"/>
</dbReference>
<dbReference type="MINT" id="P02730"/>
<dbReference type="STRING" id="9606.ENSP00000262418"/>
<dbReference type="MoonDB" id="P02730">
<property type="type" value="Curated"/>
</dbReference>
<dbReference type="MoonProt" id="P02730"/>
<dbReference type="TCDB" id="2.A.31.1.1">
<property type="family name" value="the anion exchanger (ae) family"/>
</dbReference>
<dbReference type="GlyConnect" id="1024">
<property type="glycosylation" value="1 N-Linked glycan (1 site), 1 O-Linked glycan (3 sites)"/>
</dbReference>
<dbReference type="GlyGen" id="P02730">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="P02730"/>
<dbReference type="PhosphoSitePlus" id="P02730"/>
<dbReference type="SwissPalm" id="P02730"/>
<dbReference type="BioMuta" id="SLC4A1"/>
<dbReference type="DMDM" id="114787"/>
<dbReference type="jPOST" id="P02730"/>
<dbReference type="MassIVE" id="P02730"/>
<dbReference type="PaxDb" id="P02730"/>
<dbReference type="PeptideAtlas" id="P02730"/>
<dbReference type="PRIDE" id="P02730"/>
<dbReference type="ProteomicsDB" id="51557"/>
<dbReference type="ABCD" id="P02730">
<property type="antibodies" value="35 sequenced antibodies"/>
</dbReference>
<dbReference type="Antibodypedia" id="2977">
<property type="antibodies" value="293 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000262418">
<molecule id="P02730-1"/>
<property type="protein sequence ID" value="ENSP00000262418"/>
<property type="gene ID" value="ENSG00000004939"/>
</dbReference>
<dbReference type="GeneID" id="6521"/>
<dbReference type="KEGG" id="hsa:6521"/>
<dbReference type="UCSC" id="uc002igf.5">
<molecule id="P02730-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="6521"/>
<dbReference type="DisGeNET" id="6521"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000004939.13"/>
<dbReference type="GeneCards" id="SLC4A1"/>
<dbReference type="HGNC" id="HGNC:11027">
<property type="gene designation" value="SLC4A1"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000004939">
<property type="expression patterns" value="Tissue enhanced (bone marrow, placenta)"/>
</dbReference>
<dbReference type="MalaCards" id="SLC4A1"/>
<dbReference type="MIM" id="109270">
<property type="type" value="gene+phenotype"/>
</dbReference>
<dbReference type="MIM" id="110500">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="112010">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="112050">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="130600">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="166900">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="179800">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="185020">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601550">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="601551">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="611162">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="611590">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="612653">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P02730"/>
<dbReference type="OpenTargets" id="ENSG00000004939"/>
<dbReference type="Orphanet" id="93608">
<property type="disease" value="Autosomal dominant distal renal tubular acidosis"/>
</dbReference>
<dbReference type="Orphanet" id="3202">
<property type="disease" value="Dehydrated hereditary stomatocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="93610">
<property type="disease" value="Distal renal tubular acidosis with anemia"/>
</dbReference>
<dbReference type="Orphanet" id="398088">
<property type="disease" value="Hereditary cryohydrocytosis with normal stomatin"/>
</dbReference>
<dbReference type="Orphanet" id="822">
<property type="disease" value="Hereditary spherocytosis"/>
</dbReference>
<dbReference type="Orphanet" id="98868">
<property type="disease" value="Southeast Asian ovalocytosis"/>
</dbReference>
<dbReference type="PharmGKB" id="PA35895"/>
<dbReference type="eggNOG" id="KOG1172">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157423"/>
<dbReference type="HOGENOM" id="CLU_002289_1_0_1"/>
<dbReference type="InParanoid" id="P02730"/>
<dbReference type="KO" id="K06573"/>
<dbReference type="OMA" id="PHTDYTQ"/>
<dbReference type="OrthoDB" id="265068at2759"/>
<dbReference type="PhylomeDB" id="P02730"/>
<dbReference type="TreeFam" id="TF313630"/>
<dbReference type="PathwayCommons" id="P02730"/>
<dbReference type="Reactome" id="R-HSA-1237044">
<property type="pathway name" value="Erythrocytes take up carbon dioxide and release oxygen"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-1247673">
<property type="pathway name" value="Erythrocytes take up oxygen and release carbon dioxide"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-425381">
<property type="pathway name" value="Bicarbonate transporters"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5619050">
<property type="pathway name" value="Defective SLC4A1 causes hereditary spherocytosis type 4 (HSP4), distal renal tubular acidosis (dRTA) and dRTA with hemolytic anemia (dRTA-HA)"/>
</dbReference>
<dbReference type="SIGNOR" id="P02730"/>
<dbReference type="BioGRID-ORCS" id="6521">
<property type="hits" value="26 hits in 874 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SLC4A1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P02730"/>
<dbReference type="GeneWiki" id="Band_3"/>
<dbReference type="GenomeRNAi" id="6521"/>
<dbReference type="Pharos" id="P02730">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:P02730"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="P02730">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000004939">
<property type="expression patterns" value="Expressed in trabecular bone tissue and 158 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="P02730">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P02730">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0016323">
<property type="term" value="C:basolateral plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072562">
<property type="term" value="C:blood microparticle"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030863">
<property type="term" value="C:cortical cytoskeleton"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009898">
<property type="term" value="C:cytoplasmic side of plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016021">
<property type="term" value="C:integral component of membrane"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030018">
<property type="term" value="C:Z disc"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008509">
<property type="term" value="F:anion transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0015301">
<property type="term" value="F:anion:anion antiporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030506">
<property type="term" value="F:ankyrin binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015106">
<property type="term" value="F:bicarbonate transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015108">
<property type="term" value="F:chloride transmembrane transporter activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030492">
<property type="term" value="F:hemoglobin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005452">
<property type="term" value="F:inorganic anion exchanger activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042803">
<property type="term" value="F:protein homodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043495">
<property type="term" value="F:protein-membrane adaptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006820">
<property type="term" value="P:anion transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0015701">
<property type="term" value="P:bicarbonate transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007596">
<property type="term" value="P:blood coagulation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006873">
<property type="term" value="P:cellular ion homeostasis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0006821">
<property type="term" value="P:chloride transport"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048821">
<property type="term" value="P:erythrocyte development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1904539">
<property type="term" value="P:negative regulation of glycolytic process through fructose-6-phosphate"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051354">
<property type="term" value="P:negative regulation of oxidoreductase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035811">
<property type="term" value="P:negative regulation of urine volume"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045852">
<property type="term" value="P:pH elevation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0017121">
<property type="term" value="P:plasma membrane phospholipid scrambling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072659">
<property type="term" value="P:protein localization to plasma membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051453">
<property type="term" value="P:regulation of intracellular pH"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="DisProt" id="DP01167"/>
<dbReference type="Gene3D" id="3.40.930.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR001717">
<property type="entry name" value="Anion_exchange"/>
</dbReference>
<dbReference type="InterPro" id="IPR002977">
<property type="entry name" value="Anion_exchange_1"/>
</dbReference>
<dbReference type="InterPro" id="IPR018241">
<property type="entry name" value="Anion_exchange_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR013769">
<property type="entry name" value="Band3_cytoplasmic_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011531">
<property type="entry name" value="HCO3_transpt_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR003020">
<property type="entry name" value="HCO3_transpt_euk"/>
</dbReference>
<dbReference type="InterPro" id="IPR016152">
<property type="entry name" value="PTrfase/Anion_transptr"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11453">
<property type="entry name" value="PTHR11453"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF07565">
<property type="entry name" value="Band_3_cyto"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00955">
<property type="entry name" value="HCO3_cotransp"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PRINTS" id="PR00165">
<property type="entry name" value="ANIONEXCHNGR"/>
</dbReference>
<dbReference type="PRINTS" id="PR01187">
<property type="entry name" value="ANIONEXHNGR1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01231">
<property type="entry name" value="HCO3TRNSPORT"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF55804">
<property type="entry name" value="SSF55804"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="TIGRFAMs" id="TIGR00834">
<property type="entry name" value="ae"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00219">
<property type="entry name" value="ANION_EXCHANGER_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00220">
<property type="entry name" value="ANION_EXCHANGER_2"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0039">Anion exchange</keyword>
<keyword id="KW-0095">Blood group antigen</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0250">Elliptocytosis</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0360">Hereditary hemolytic anemia</keyword>
<keyword id="KW-0406">Ion transport</keyword>
<keyword id="KW-0449">Lipoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0564">Palmitate</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<keyword id="KW-0813">Transport</keyword>
<feature type="chain" description="Band 3 anion transport protein" id="PRO_0000079209">
<location>
<begin position="1"/>
<end position="911"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="1"/>
<end position="403"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="36">
<location>
<begin position="404"/>
<end position="427"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="36">
<location>
<begin position="428"/>
<end position="435"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="36">
<location>
<begin position="436"/>
<end position="456"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="457"/>
<end position="459"/>
</location>
</feature>
<feature type="transmembrane region" description="Discontinuously helical; Name=3" evidence="36">
<location>
<begin position="460"/>
<end position="476"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="36">
<location>
<begin position="477"/>
<end position="485"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="36">
<location>
<begin position="486"/>
<end position="506"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="507"/>
<end position="518"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="36">
<location>
<begin position="519"/>
<end position="541"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="36">
<location>
<begin position="542"/>
<end position="570"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="36">
<location>
<begin position="571"/>
<end position="591"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="592"/>
<end position="602"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="36">
<location>
<begin position="603"/>
<end position="623"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="36">
<location>
<begin position="624"/>
<end position="663"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=8" evidence="36">
<location>
<begin position="664"/>
<end position="684"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="685"/>
<end position="700"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=9" evidence="36">
<location>
<begin position="701"/>
<end position="719"/>
</location>
</feature>
<feature type="transmembrane region" description="Discontinuously helical; Name=10" evidence="36">
<location>
<begin position="720"/>
<end position="737"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="738"/>
<end position="760"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=11" evidence="36">
<location>
<begin position="761"/>
<end position="781"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=12" evidence="36">
<location>
<begin position="782"/>
<end position="800"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="801"/>
<end position="838"/>
</location>
</feature>
<feature type="intramembrane region" description="Discontinuously helical" evidence="36">
<location>
<begin position="839"/>
<end position="869"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="36">
<location>
<begin position="870"/>
<end position="911"/>
</location>
</feature>
<feature type="region of interest" description="Globular">
<location>
<begin position="55"/>
<end position="290"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with ANK1" evidence="57">
<location>
<begin position="176"/>
<end position="185"/>
</location>
</feature>
<feature type="region of interest" description="Dimerization arm">
<location>
<begin position="304"/>
<end position="357"/>
</location>
</feature>
<feature type="region of interest" description="Involved in anion transport">
<location>
<begin position="559"/>
<end position="630"/>
</location>
</feature>
<feature type="site" description="Important for anion transport">
<location>
<position position="590"/>
</location>
</feature>
<feature type="site" description="Important for anion-proton cotransport">
<location>
<position position="681"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylmethionine" evidence="37 38">
<location>
<position position="1"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12 30">
<location>
<position position="8"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12 30">
<location>
<position position="21"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="30">
<location>
<position position="46"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="185"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="350"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="359"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="12">
<location>
<position position="904"/>
</location>
</feature>
<feature type="lipid moiety-binding region" description="S-palmitoyl cysteine" evidence="29">
<location>
<position position="843"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) (complex) asparagine" evidence="10 34">
<location>
<position position="642"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_057833" evidence="39">
<location>
<begin position="1"/>
<end position="65"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_058035" evidence="23">
<original>P</original>
<variation>H</variation>
<location>
<position position="27"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5035." id="VAR_014612" evidence="9 26 49 56">
<original>D</original>
<variation>A</variation>
<location>
<position position="38"/>
</location>
</feature>
<feature type="sequence variant" description="Found in patients with hemolytic anemia; unknown pathological significance; Montefiore; dbSNP:rs45562031." id="VAR_000798" evidence="45 47">
<original>E</original>
<variation>K</variation>
<location>
<position position="40"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34700496." id="VAR_036693">
<original>D</original>
<variation>E</variation>
<location>
<position position="45"/>
</location>
</feature>
<feature type="sequence variant" description="In Di(a)/Memphis-II antigen; dbSNP:rs5036." id="VAR_000799" evidence="9 25 27 28 43 56">
<original>K</original>
<variation>E</variation>
<location>
<position position="56"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13306787." id="VAR_039290">
<original>E</original>
<variation>K</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs13306788." id="VAR_058036" evidence="9">
<original>E</original>
<variation>D</variation>
<location>
<position position="72"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs781490287." id="VAR_039291" evidence="49">
<original>L</original>
<variation>M</variation>
<location>
<position position="73"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Cape Town; dbSNP:rs28929480." id="VAR_013784" evidence="18">
<original>E</original>
<variation>K</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5037." id="VAR_014613">
<original>R</original>
<variation>S</variation>
<location>
<position position="112"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Fukoka; dbSNP:rs121912749." id="VAR_013785" evidence="9">
<original>G</original>
<variation>R</variation>
<location>
<position position="130"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Mondego." id="VAR_013786" evidence="50">
<original>P</original>
<variation>S</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Boston." id="VAR_013787" evidence="48">
<original>A</original>
<variation>D</variation>
<location>
<position position="285"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Tuscaloosa; dbSNP:rs28931583." id="VAR_000800" evidence="19">
<original>P</original>
<variation>R</variation>
<location>
<position position="327"/>
</location>
</feature>
<feature type="sequence variant" description="In SAO; increased rigidity of the erythrocyte membrane leading to increased resistance to shear stress and increased resistance to P.falciparum." id="VAR_000801" evidence="22 28">
<location>
<begin position="400"/>
<end position="408"/>
</location>
</feature>
<feature type="sequence variant" description="In NFLD+ antigen; dbSNP:rs1048804130." id="VAR_058037" evidence="8">
<original>E</original>
<variation>D</variation>
<location>
<position position="429"/>
</location>
</feature>
<feature type="sequence variant" description="In ELO antigen; dbSNP:rs373768879." id="VAR_013788">
<original>R</original>
<variation>W</variation>
<location>
<position position="432"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5018." id="VAR_014614">
<original>I</original>
<variation>F</variation>
<location>
<position position="442"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Benesov." id="VAR_013789" evidence="48">
<original>G</original>
<variation>E</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Yamagata." id="VAR_058038" evidence="9">
<original>G</original>
<variation>R</variation>
<location>
<position position="455"/>
</location>
</feature>
<feature type="sequence variant" description="In FR(a+) antigen; dbSNP:rs121912756." id="VAR_013790" evidence="15">
<original>E</original>
<variation>K</variation>
<location>
<position position="480"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Coimbra; also in AR-dRTA; dbSNP:rs28931584." id="VAR_013791" evidence="13 50">
<original>V</original>
<variation>M</variation>
<location>
<position position="488"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Bicetre I; dbSNP:rs1398477044." id="VAR_013792" evidence="51">
<original>R</original>
<variation>C</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Pinhal." id="VAR_058039" evidence="7">
<original>R</original>
<variation>H</variation>
<location>
<position position="490"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs45568837." id="VAR_025090" evidence="56">
<original>E</original>
<variation>K</variation>
<location>
<position position="508"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Dresden; dbSNP:rs868742796." id="VAR_000802" evidence="47">
<original>R</original>
<variation>C</variation>
<location>
<position position="518"/>
</location>
</feature>
<feature type="sequence variant" description="In RB(A) antigen; dbSNP:rs879202054." id="VAR_000803">
<original>P</original>
<variation>L</variation>
<location>
<position position="548"/>
</location>
</feature>
<feature type="sequence variant" description="In TR(A) antigen." id="VAR_013793">
<original>K</original>
<variation>N</variation>
<location>
<position position="551"/>
</location>
</feature>
<feature type="sequence variant" description="In WARR antigen." id="VAR_000804">
<original>T</original>
<variation>I</variation>
<location>
<position position="552"/>
</location>
</feature>
<feature type="sequence variant" description="In VG(a) antigen." id="VAR_013794">
<original>Y</original>
<variation>H</variation>
<location>
<position position="555"/>
</location>
</feature>
<feature type="sequence variant" description="In WD(a) antigen; dbSNP:rs121912743." id="VAR_000805">
<original>V</original>
<variation>M</variation>
<location>
<position position="557"/>
</location>
</feature>
<feature type="sequence variant" description="In NFLD+ antigen." id="VAR_058040" evidence="8">
<original>P</original>
<variation>A</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In BOW antigen." id="VAR_013795" evidence="8">
<original>P</original>
<variation>S</variation>
<location>
<position position="561"/>
</location>
</feature>
<feature type="sequence variant" description="In WU antigen; dbSNP:rs551784583." id="VAR_013796">
<original>G</original>
<variation>A</variation>
<location>
<position position="565"/>
</location>
</feature>
<feature type="sequence variant" description="In KREP antigen." id="VAR_013797">
<original>P</original>
<variation>A</variation>
<location>
<position position="566"/>
</location>
</feature>
<feature type="sequence variant" description="In PN(a) antigen; dbSNP:rs1393742050." id="VAR_013798">
<original>P</original>
<variation>S</variation>
<location>
<position position="566"/>
</location>
</feature>
<feature type="sequence variant" description="In BP(a) antigen." id="VAR_013799">
<original>N</original>
<variation>K</variation>
<location>
<position position="569"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5019." id="VAR_014615">
<original>M</original>
<variation>L</variation>
<location>
<position position="586"/>
</location>
</feature>
<feature type="sequence variant" description="In AD-dRTA; reduced red cell sulfate transport and altered glycosylation of the red cell band 3 N-glycan chain; dbSNP:rs121912745." id="VAR_015104" evidence="52">
<original>R</original>
<variation>C</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In AD-dRTA; dbSNP:rs121912744." id="VAR_015105" evidence="52 53">
<original>R</original>
<variation>H</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In AD-dRTA; dbSNP:rs121912745." id="VAR_015106" evidence="53">
<original>R</original>
<variation>S</variation>
<location>
<position position="589"/>
</location>
</feature>
<feature type="sequence variant" description="In dRTA-HA; dbSNP:rs121912754." id="VAR_039292" evidence="21">
<original>R</original>
<variation>H</variation>
<location>
<position position="602"/>
</location>
</feature>
<feature type="sequence variant" description="In AD-dRTA; detected subapically and at the apical membrane as well as at the basolateral membrane in contrast to the normal basolateral appearance of wild-type protein; dbSNP:rs878853002." id="VAR_058041" evidence="20">
<original>G</original>
<variation>R</variation>
<location>
<position position="609"/>
</location>
</feature>
<feature type="sequence variant" description="In AD-dRTA; markedly increased red cell sulfate transport but almost normal red cell iodide transport; dbSNP:rs121912746." id="VAR_015107" evidence="52">
<original>S</original>
<variation>F</variation>
<location>
<position position="613"/>
</location>
</feature>
<feature type="sequence variant" description="In SW(a+) antigen; dbSNP:rs121912757." id="VAR_013800" evidence="16">
<original>R</original>
<variation>Q</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="sequence variant" description="In SW(a+) antigen; dbSNP:rs121912758." id="VAR_013801" evidence="16">
<original>R</original>
<variation>W</variation>
<location>
<position position="646"/>
</location>
</feature>
<feature type="sequence variant" description="In HG(a) antigen; dbSNP:rs372514760." id="VAR_013802">
<original>R</original>
<variation>C</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In MO(a) antigen; dbSNP:rs758868427." id="VAR_013803">
<original>R</original>
<variation>H</variation>
<location>
<position position="656"/>
</location>
</feature>
<feature type="sequence variant" description="In WR(a) antigen; dbSNP:rs75731670." id="VAR_000806" evidence="42">
<original>E</original>
<variation>K</variation>
<location>
<position position="658"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Tambau." id="VAR_058042" evidence="24">
<original>M</original>
<variation>K</variation>
<location>
<position position="663"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Osnabruck II." id="VAR_000807" evidence="47">
<location>
<position position="663"/>
</location>
</feature>
<feature type="sequence variant" description="In CHC; Blackburn; induces abnormal cations sodium and potassium fluxes; decreases anion chloride transport; dbSNP:rs863225463." id="VAR_039293" evidence="25">
<original>L</original>
<variation>P</variation>
<location>
<position position="687"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5022." id="VAR_014616">
<original>I</original>
<variation>V</variation>
<location>
<position position="688"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5023." id="VAR_014617">
<original>S</original>
<variation>G</variation>
<location>
<position position="690"/>
</location>
</feature>
<feature type="sequence variant" description="In dRTA-HA and dRTA-NRC; impairs expression at the cell membrane; dbSNP:rs121912748." id="VAR_015171" evidence="11 21 31 54">
<original>G</original>
<variation>D</variation>
<location>
<position position="701"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Horam; induces abnormal cations sodium and potassium fluxes; decreases anion chloride transport." id="VAR_039294" evidence="25">
<original>D</original>
<variation>Y</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Most." id="VAR_013804" evidence="17 48">
<original>L</original>
<variation>P</variation>
<location>
<position position="707"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Okinawa." id="VAR_013805" evidence="9">
<original>G</original>
<variation>R</variation>
<location>
<position position="714"/>
</location>
</feature>
<feature type="sequence variant" description="In CHC; Hemel; induces abnormal cations sodium and potassium fluxes; decreases anion chloride transport; dbSNP:rs863225461." id="VAR_039295" evidence="25">
<original>S</original>
<variation>P</variation>
<location>
<position position="731"/>
</location>
</feature>
<feature type="sequence variant" description="In CHC; Hurstpierpont; induces abnormal cations sodium and potassium fluxes; decreases anion chloride transport; dbSNP:rs863225462." id="VAR_039296" evidence="25">
<original>H</original>
<variation>R</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Prague II; induces abnormal cations sodium and potassium fluxes; decreases anion chloride transport; dbSNP:rs121912755." id="VAR_013806" evidence="9 17 25 40">
<original>R</original>
<variation>Q</variation>
<location>
<position position="760"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Hradec Kralove; dbSNP:rs373916826." id="VAR_013807" evidence="9 17 40">
<original>R</original>
<variation>W</variation>
<location>
<position position="760"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Chur; dbSNP:rs121912741." id="VAR_013808" evidence="46">
<original>G</original>
<variation>D</variation>
<location>
<position position="771"/>
</location>
</feature>
<feature type="sequence variant" description="In dRTA-NRC; dbSNP:rs121912753." id="VAR_039297" evidence="21">
<original>S</original>
<variation>P</variation>
<location>
<position position="773"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Napoli II." id="VAR_013809" evidence="49">
<original>I</original>
<variation>N</variation>
<location>
<position position="783"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Jablonec; dbSNP:rs1167814744." id="VAR_013810" evidence="17 40">
<original>R</original>
<variation>C</variation>
<location>
<position position="808"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Nara; dbSNP:rs866727908." id="VAR_013811" evidence="9">
<original>R</original>
<variation>H</variation>
<location>
<position position="808"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs5025." id="VAR_014618">
<original>R</original>
<variation>H</variation>
<location>
<position position="832"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Birmingham." id="VAR_013812" evidence="17 48">
<original>H</original>
<variation>P</variation>
<location>
<position position="834"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Tokyo; dbSNP:rs121912750." id="VAR_013813" evidence="55">
<original>T</original>
<variation>A</variation>
<location>
<position position="837"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Philadelphia." id="VAR_013814" evidence="9 17 48 51">
<original>T</original>
<variation>M</variation>
<location>
<position position="837"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Nagoya." id="VAR_058043" evidence="9">
<original>T</original>
<variation>R</variation>
<location>
<position position="837"/>
</location>
</feature>
<feature type="sequence variant" description="In dRTA-HA." id="VAR_015109" evidence="11">
<location>
<position position="850"/>
</location>
</feature>
<feature type="sequence variant" description="In Di(a)/Memphis-II antigen; dbSNP:rs2285644." id="VAR_000808" evidence="9 43">
<original>P</original>
<variation>L</variation>
<location>
<position position="854"/>
</location>
</feature>
<feature type="sequence variant" description="In AD-dRTA; impairs expression at the cell membrane; dbSNP:rs121912751." id="VAR_015108" evidence="11 31">
<original>A</original>
<variation>D</variation>
<location>
<position position="858"/>
</location>
</feature>
<feature type="sequence variant" description="Polymorphism; dbSNP:rs5026." id="VAR_014619" evidence="32 56">
<original>V</original>
<variation>I</variation>
<location>
<position position="862"/>
</location>
</feature>
<feature type="sequence variant" description="In acanthocytosis; slightly increases transporter activity; impairs expression at the cell membrane; dbSNP:rs121912759." id="VAR_013815" evidence="34 44">
<original>P</original>
<variation>L</variation>
<location>
<position position="868"/>
</location>
</feature>
<feature type="sequence variant" description="In SPH4; Prague III; dbSNP:rs28931585." id="VAR_013816" evidence="17 18 40">
<original>R</original>
<variation>W</variation>
<location>
<position position="870"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs expression at the cell membrane." evidence="34">
<original>E</original>
<variation>A</variation>
<variation>R</variation>
<location>
<position position="85"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs expression at the cell membrane." evidence="34">
<original>R</original>
<variation>A</variation>
<variation>E</variation>
<variation>S</variation>
<location>
<position position="283"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of N-glycosylation site." evidence="34">
<original>N</original>
<variation>D</variation>
<location>
<position position="642"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs expression at the cell membrane." evidence="34">
<original>E</original>
<variation>Q</variation>
<location>
<position position="681"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AA sequence." ref="9" evidence="57">
<original>M</original>
<variation>D</variation>
<location>
<position position="11"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 9; AA sequence." ref="9" evidence="57">
<original>E</original>
<variation>EE</variation>
<location>
<position position="68"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; ABD74692." ref="3" evidence="57">
<original>Q</original>
<variation>H</variation>
<location>
<position position="759"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="9"/>
<end position="12"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="58"/>
<end position="66"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="68"/>
<end position="70"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="73"/>
<end position="88"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="90"/>
<end position="92"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="104"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="118"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="128"/>
<end position="141"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="147"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="150"/>
<end position="157"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="164"/>
<end position="169"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="173"/>
<end position="175"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="188"/>
<end position="190"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="195"/>
<end position="200"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="212"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="226"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="241"/>
<end position="251"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="256"/>
<end position="258"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="262"/>
<end position="270"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="278"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="292"/>
<end position="300"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="304"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="319"/>
<end position="321"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="329"/>
<end position="332"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="333"/>
<end position="335"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="336"/>
<end position="347"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="349"/>
<end position="351"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="383"/>
<end position="393"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="394"/>
<end position="400"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="403"/>
<end position="430"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="431"/>
<end position="433"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="437"/>
<end position="454"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="466"/>
<end position="481"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="486"/>
<end position="506"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="509"/>
<end position="515"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="518"/>
<end position="546"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="570"/>
<end position="593"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="594"/>
<end position="597"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="599"/>
<end position="607"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="609"/>
<end position="623"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="655"/>
<end position="657"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="663"/>
<end position="666"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="668"/>
<end position="689"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="703"/>
<end position="718"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="728"/>
<end position="735"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="761"/>
<end position="780"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="785"/>
<end position="799"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="804"/>
<end position="813"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="823"/>
<end position="827"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="828"/>
<end position="831"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="832"/>
<end position="850"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="854"/>
<end position="858"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="859"/>
<end position="873"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="875"/>
<end position="877"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="880"/>
<end position="882"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="883"/>
<end position="886"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1HYN"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2BTA"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4KY9"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4YZF"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P04919"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P23562"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10580570"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10738034"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10745622"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10861210"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10926824"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10942405"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10942416"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11049968"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11061863"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11155072"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11208088"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11380459"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1378323"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14734552"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15211439"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1538405"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15813913"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16227998"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16252102"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1678289"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1722314"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1885574"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1998697"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20151848"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21849667"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23219802"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24121512"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26049106"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26542571"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="2790053"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="701248"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7506871"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7530501"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7665627"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7812009"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8206915"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8343110"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8471774"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8547122"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8640229"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8943874"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9012689"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9207478"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9233560"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9312167"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9600966"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9854053"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9973643"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source ref="5"/>
</evidence>
<evidence key="57" type="ECO:0000305"/>
<sequence length="911" mass="101792" checksum="35EC3EE7AFF27D2F" modified="1990-04-01" version="3">MEELQDDYEDMMEENLEQEEYEDPDIPESQMEEPAAHDTEATATDYHTTSHPGTHKVYVELQELVMDEKNQELRWMEAARWVQLEENLGENGAWGRPHLSHLTFWSLLELRRVFTKGTVLLDLQETSLAGVANQLLDRFIFEDQIRPQDREELLRALLLKHSHAGELEALGGVKPAVLTRSGDPSQPLLPQHSSLETQLFCEQGDGGTEGHSPSGILEKIPPDSEATLVLVGRADFLEQPVLGFVRLQEAAELEAVELPVPIRFLFVLLGPEAPHIDYTQLGRAAATLMSERVFRIDAYMAQSRGELLHSLEGFLDCSLVLPPTDAPSEQALLSLVPVQRELLRRRYQSSPAKPDSSFYKGLDLNGGPDDPLQQTGQLFGGLVRDIRRRYPYYLSDITDAFSPQVLAAVIFIYFAALSPAITFGGLLGEKTRNQMGVSELLISTAVQGILFALLGAQPLLVVGFSGPLLVFEEAFFSFCETNGLEYIVGRVWIGFWLILLVVLVVAFEGSFLVRFISRYTQEIFSFLISLIFIYETFSKLIKIFQDHPLQKTYNYNVLMVPKPQGPLPNTALLSLVLMAGTFFFAMMLRKFKNSSYFPGKLRRVIGDFGVPISILIMVLVDFFIQDTYTQKLSVPDGFKVSNSSARGWVIHPLGLRSEFPIWMMFASALPALLVFILIFLESQITTLIVSKPERKMVKGSGFHLDLLLVVGMGGVAALFGMPWLSATTVRSVTHANALTVMGKASTPGAAAQIQEVKEQRISGLLVAVLVGLSILMEPILSRIPLAVLFGIFLYMGVTSLSGIQLFDRILLLFKPPKYHPDVPYVKRVKTWRMHLFTGIQIICLAVLWVVKSTPASLALPFVLILTVPLRRVLLPLIFRNVELQCLDADDAKATFDEEEGRDEYDEVAMPV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

